Focus

Media

• DoubleBlind Mag • Lucid News • Psilocybin Alpha • Psychedelic Finance • Psychedelic Times • Psymposia • Reality Sandwich • Reset.Me • Shroom Boom • The Third Wave • The Trip Report • Microdose • Psillow • Psychedelic Science Review • The Green Light • The Sporing Company • The Awake Network • Report on Psychedelics • Psychedelic Invest • Kahpi • Medicine Hunter • High Existence • Aya Visionary • McKenna Academy • Psychedelics Asia • Kosmicare • MOOF • Psilopedia • Adventures Through The Mind • Alan Aldous • Psyched • Psychedelic Spotlight • The Psychedelics Analyst • Psyched Substance • It's Psychedelic Baby Magazine • Shroom Stocks • Shroom Street • Magic Agency • VICE • Drug Science • Psychedelics Today • Gaia • PRØHBTD • Psychedelic Parenting • Seeing Machine Films • PsyFamily • PsychonautWiki • Enpsychedelia • Chacruna • Goop • Psychedelic Stockwatch • Neuly • Psychedelic News Wire • Integration Communications • Mattio Communications • Ketamine Media • Ketamine News • Andromeda Entertainment • Launchpad Partners • Global Trac Solutions • Salar Group • Puff Digital • PuraPhy • Mind Things • Trippingly • The Weekly Trip • Think Wilder • Inside the Jar • Bloomers • How To Use Psychedelics • Mr. Psychedelic Law • Entheogenesis Australis • MAPS • Society for Psychedelic Outreach Reform and Education (SPORE) • Uthymia • ResearchHub • Trent & Company
• Sr Director, Head of Commercialization and Patient Access

Medical

• Xpira Pharmaceuticals

Mescaline

• Shamanic Space • Journey Colab • XPhyto • Mr. Psychedelic Law • Entheogenesis Australis • Limina Foundation • Society for Psychedelic Outreach Reform and Education (SPORE) • MagicMed Industries
• Comparative Acute Effects of LSD, Psilocybin and Mescaline • Effects of Hallucinogens and Other Drugs on Mood and Performance • Personality and Drug Use (PDU) • Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Mindfulness

• Nucleus • Nurosene

Noribogaine

• DemeRx • Clear Sky Recovery

Podcast

• Plant Medicine • Mind Manifest • High Existence • Remolina Coaching • Modern Psychedelics • Psychedelic Renaissance Podcast • Mikeadelic • Adventures Through The Mind • Psyched • It's Psychedelic Baby Magazine • PsychEd Podcast • Psychedelics Today • Business Trip • Mind Things • Entheogenesis Australis

Policy

• The Clarity Project • Young Wave (Jauna Banga) • Healing Advocacy Fund • Reform Conference • NoBox Philipines • Decriminalize Denver • Students for Sensible Drug Policy (SSDP) • Espolea • Polskie Towarzystwo Psychodeliczne • Decriminalize Nature Canada • Decriminalize Nature DC • Drug Policy Alliance • Mr. Psychedelic Law • Entheogenesis Australis • MAPS • Society for Psychedelic Outreach Reform and Education (SPORE)

Psilocybin

• Alphamind Brands • Anahit • Bright Minds • Cilo Cybin • Cybin Technologies • Cybin Therapeutics • EGF Theramed Health Corp. • Ehave • Ei.Ventures • Green Parrot Labs • HAVN Life • Hikma • Mindset Pharma • Minerco, Inc • Thoughtful Brands, Inc. • Neon Mind • New Wave Corp. • Octarine • OmTerra • Optosom • Pharmadelic Labs • Psilocin Corp. • Psilocybin Technology • Psybio Therapeutics • Psyched Wellness Corp. • Psychedelic Insights • Pure Extracts • Rapid Therapeutic Science Laboratories • Red Light Holland Corp. • Roadman • The Emmes Company, LLC • Think Myco • Tripsitters • Verrian • Xenomics • atai Life Sciences • Braxia Scientific • COMPASS Pathways • Cybin • Flourish Mushroom Labs Inc. • Frontier Neurochem • Mydecine Innovations Group Inc. • OLP Therapeutics • Pfizer • Rxoid • Sansero • Silo Wellness • WGG • Yield Growth Corp • The Buena Vida • Luz Eterna Retreats • Magic Mushrooms Dispensary • The Myco Grow • Truffles Therapy • Het Wonder Van Bestaan • Binnenreizen • Shamanic Space • A Whole New High • Inward Bound • Trip Safe • New Moon Psychedelic Retreats • Kiyumi • Therapeutic Sitting Service • Plant Medicine Miracles • Psilohuasca • Essence Institute • Truffle Healing • St. Vincent's Hospital, Melbourne • Earth Resonance • ShroomsDirect • Blue Goba • Psilo Supplements • Champignon Magique • Medicinal Mushroom Dispensary • Eleusian Biosciences • 920 Coalition • Microdose Nature • Quality Spores • Midwest Grow Kits • North Spore • Atman Retreat • Cyber-Shrooms • ProviThor • Psilo Retreat • Earthly Microdosing • Osmosis • Soul Treats • Sero • Micro Mushroom Resource Centre • Beckley Psytech • Azarius • CaaMTech • Aion Therapeutic • PCAI • IntelGenx • CannaGlobal Wellness • The Lundquist Institute • Tryp Therapeutics • Rritual • Captiva Verde • Magical Brands • Canadian Psilocybin Collective • M2BIO • Shroomery • PsiloBrain • Mindcure • Smallhold • Empyrean • Four Sigmatic • BioPharm • Aquilino Cancer Center • Pharmadrug • Better Plant Sciences • Pharmather • Cannsun Medhel • Pilz BioScience • Silo Pharma • Primo Nutraceuticals Inc. • Medcan Biotechnologies • Psilocybrand • Allied Corp • Gwella Mushrooms • Kind Stranger • Headland • Mera Life Sciences • The Entheogen Genome Project • Soul Cybin • Leiio Wellness • bluemasi • XPhyto • Eighth Gen Therapeutics • Maylo Therapeutics • Incannex • Monash • NeonMind Biosciences Inc. • AIkido Pharma • Psyence • Alkemist Labs • Namaste Technologies • Conscious Mind • Sunstone Therapies • AMRI • GoodCap • ATMA Journey Centers Inc. • Atitlantis • Optimi Health • Syreon Research Institute • MYND Life Sciences Inc. • Forest Medicine Coaching • Micro-dosing for Healing • California Center for Psychedelic Therapy • Knowde Group Inc. • Lattice Biologics • Halucenex • CURE Pharmaceutical • The Sentinel • Psirenity • PsiloTec • Levitee Labs • Cannabics Pharmaceuticals • Mycrodose Therapeutics • Cubed3 Biotech • Mr. Psychedelic Law • High Rise • Lennham Pharmaceuticals • Entheogenesis Australis • Limina Foundation • Healing Advocacy Fund • Society for Psychedelic Outreach Reform and Education (SPORE) • Usona Institute • Numinus • Core One Labs • MagicMed Industries • Wesana Health • Nova Mentis Life Science Corp. • Lobe Sciences • Eversio Wellness • Filament Health • Ocean Bio • Apex Labs • 3Amigos Psilocybin • Albert Labs • MycoMedia Life Sciences • MindLift • Circadian Wellness • Diaspora Psychedelic Society • Zylorion • Within Center • MagicMushroomKit.ca
• Director, Investor Relations • Postdoctoral Research Fellow/Research Associate
• The pharmacology of psilocybin • Response of cluster headache to psilocybin and LSD • Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance • Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study • Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action • Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer • Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects • Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin • Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms • Cross tolerance between LSD and psilocybin • Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study • Long-term follow-up of psilocybin-facilitated smoking cessation • Prediction of psilocybin response in healthy volunteers • Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness • Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder • Psilocybin with psychological support for treatment-resistant depression: six-month follow-up • Potential therapeutic effects of psilocybin • Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction • Reactions to psilocybin administered in a supportive environment. • Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later • Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction • Enzymatic synthesis of psilocybin • Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial • Effects of psilocybin therapy on personality structure • Biosynthesis of psilocybin • Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin • Comparison of the reactions induced by psilocybin and LSD-25 in man • Psilocybin–summary of knowledge and new perspectives • Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis • Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial • Mescaline, LSD, Psilocybin, and Personality Change a Review • Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis • Effects of psilocybin on time perception and temporal control of behaviour in humans • Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA • Patients' accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression • Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin • Patient experiences of psilocybin-assisted psychotherapy: an interpretative phenomenological analysis • Increased activation of indirect semantic associations under psilocybin • Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies • The occurrence of psilocybin in Gymnopilus species • Psilocybin: Magic Mushroom Grower's Guide: A Handbook for Psilocybin Enthusiasts • Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers • Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study • 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man—a PET study with raclopride • Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin • Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin • Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors • Psilocybin, psychological distress, and suicidality • Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels • Finding the self by losing the self: Neural correlates of ego‐dissolution under psilocybin • Psilocybin Mushroom (Psilocybe semilanceata) Intoxication with Myocardial Infarction • The effects of psilocybin on primary process content in language. • Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression • Effects of LSD-25, psilocybin and psilocin on temporal lobe EEG patterns & learned behavior in the cat. • Effect of psilocybin on empathy and moral decision-making • Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin • Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences • Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations • Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects • The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act • Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception • Psilocybin impairs high-level but not low-level motion perception • Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors • Baeocystin and norbaeocystin: new analogs of psilocybin from Psilocybe baeocystis • The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers • Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers • Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning • Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans • Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers • The psilocybin mushroom pandemic • The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval • Dephosphorylation of psilocybin in the intact mouse • Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression • Psilocybin-induced stimulus control in the rat • The enzymic dephosphorylation and oxidation of psilocybin and pscilocin by mammalian tissue homogenates • Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans • Production of psilocybin in Psilocybe baeocystis saprophytic culture • The relationship between the metabolic fate and pharmacological actions of serotonin, bufotenine and psilocybin • Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological … • Sub-acute effects of psilocybin on empathy, creative thinking, and subjective well-being • Serotonin, psilocybin, and body dysmorphic disorder: a case report • DARK classics in chemical neuroscience: Psilocybin • Neurometabolic effects of psilocybin, 3, 4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers: a double-blind, placebo-controlled … • Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations • SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist • Some observations on psilocybin, a new hallucinogen, in volunteer subjects. • Effects of varied doses of psilocybin on time interval reproduction in human subjects • Occurrence of psilocybin in various higher fungi from several European countries • Hallucinogen persisting perception disorder after psilocybin consumption: a case study • Psychopathological, neuroendocrine and autonomic effects of 3, 4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy … • Mescaline, lysergic acid diethylamide and psilocybin: comparison of clinical syndromes, effects on color perception and biochemical measures • Occurrence of psilocybin and psilocin in certain Gonocybe and Psilocybe species. • Effects of the 5-HT 2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of … • Occurrence of Psilocybin/Psilocin in Pluteus Salicinus (Pluteaceae) • Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2, 4, 5-trimethoxyamphetamine • The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms • The production of psilocybin in submerged culture by Psilocybe cubensis • Persistent psychiatric symptoms after eating psilocybin mushrooms. • Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the … • Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, USA • GLC‐mass spectral analysis of psilocin and psilocybin • Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance • Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man • The problem of psilocybin mushroom abuse • Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man • Determination of psilocybin in Psilocybe semilanceata using high-performance liquid chromatography on a silica column • Dephosphorylation of psilocybin to psilocin by alkaline phosphatase • Isolation of psilocybin from Psilocybe argentipes and its determination in specimens of some mushrooms • Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow • Pharmacokinetics of escalating doses of oral psilocybin in healthy adults • Psilocybin for treating substance use disorders? • Personality trait dependent performance under psilocybin. • The occurrence of psilocybin and psilocin in Finnish Fungi • Inter-relations of the effects of psilocybin on subjective sensation, photopic critical frequency of fusion, and circulating non-esterified fatty acids • … experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT • Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT 2A and 5-HT 1A agonist psilocybin • Psilocybin-induced contraction of nearby visual space • Production options for psilocybin: making of the magic • The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations • Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences • Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects • The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity • Changes in spider webs brought about by mescaline, psilocybin and an increase in body weight • Analysis of psilocybin and psilocin in Psilocybe subcubensis GUZMAN by ion mobility spectrometry and gas chromatography–mass spectrometry • Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression • Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of “magic mushroom” • Occurrence of psilocybin and baeocystin in the genus Inocybe (Fr.) Fr • Quantitative analysis of psilocybin and psilocin and psilocybe baecystis (singer and smith) by high-performance liquid chromatography and by thin-layer … • Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications • Occurrence of psilocybin, psilocin and baeocystin in Gymnopilus purpuratus • A new behavior change program using psilocybin • Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans • Baeocystin, a mono-methyl analog of psilocybin from Psilocybe baeocystis saprophytic culture • The content of psilocybin in Norwegian Psilocybe semilanceata • Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat • Effect of Psilocybin, LSD, and mescaline on small, involuntary eye movements • Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination • Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens • Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis • Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and‡9-THC using the micronucleus test • Role of psilocybin in the treatment of depression • The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis • Return of the psychedelics: Psilocybin for treatment resistant depression • Neuroticism is associated with challenging experiences with psilocybin mushrooms • Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study • Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer • The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions • The quantitation of psilocybin in hallucinogenic mushrooms using high performance liquid chromatography • Psilocybin-assisted therapy: a review of a novel treatment for psychiatric disorders • Some biochemical studies on psilocybin and psilocin • Use of the classic hallucinogen psilocybin for treatment of existential distress associated with cancer • More realistic forecasting of future life events after psilocybin for treatment-resistant depression • Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (Earle) Singer • In vivo production of psilocybin in E. coli • Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen • Analysis of psilocybin and psilocin in mushroom extracts by reversed-phase high performance liquid chromatography • The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary … • Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress • Clinical syndromes and biochemical alterations following mescaline, lysergic acid diethylamide, psilocybin and a combination of the three psychotomimetic drugs • Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana Heim • Ethnobotany of psilocybin mushrooms, especially Psilocybe cubensis • Production of cross-tolerance to psychosis-producing doses of lysergic acid diethylamide and psilocybin • Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame • Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase‐Enhanced Reactions • Detection of psilocybin and psilocin in Norwegian species of Pluteus and Conocybe • Psilocybin and obsessive compulsive disorder • Psilocybin in Finnish Psilocybe semilanceata • Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi • Improvements to the synthesis of psilocybin and a facile method for preparing the O-acetyl prodrug of psilocin • Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner • A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment • Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat • d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: mechanism of action and potential therapeutic applications in mood disorders • Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids • Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon. • Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant … • Psilocybin and MDMA reduce costly punishment in the Ultimatum Game • The phenomenology and potential religious import of states of consciousness facilitated by psilocybin • Emotions and brain function are altered up to one month after a single high dose of psilocybin • Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat • Scalable hybrid synthetic/biocatalytic route to psilocybin • THE HALLUCINOGENIC MUSHROOMS OF MEXICO AND PSILOCYBIN: A BIBLIOGRAPHY (Second printing, with corrections and addenda) • Psilocybin induces time-dependent changes in global functional connectivity • Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin • A novel extraction procedure for psilocybin and psilocin determination in mushroom samples. • Monoamine biosynthesis via a noncanonical calcium-activatable aromatic amino acid decarboxylase in psilocybin mushroom • Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin • Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition • Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder • Psilocybin in Mycelkulturen von Inocybe aeruginascens • Konstitutionsaufklärung und synthese von psilocybin • Replication and extension of a model predicting response to psilocybin • Psilocybin-induced autonomic, perceptual, and behavioral change • Comparison of the discriminative stimulus properties of Δ9-THC and psilocybin in rats • Psilocybin and Mental Health–Don't Lose Control • Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role? • Effects of psilocybin, dimethyltryptamine, mescaline and various allergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio) • Effects of the psychodysleptic drug psilocybin on visual perception. Changes in brightness preference • The effects of psilocybin on a test of after-image perception • Formation of blue oxidation product from psilocybin • Psilocybin: good trip or bad trip • A technique for the rapid isolation and identification of psilocin from psilocin/psilocybin-containing mushrooms • Psilocybin-containing mushrooms • Sacred mushroom of visions: Teonanacatl: A sourcebook on the psilocybin mushroom • Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection • Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin • Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris (2, 2′-bipyridyl) ruthenium (II) chemiluminescence … • High dose psilocybin is associated with positive subjective effects in healthy volunteers • Simultaneous Production of Psilocybin and a Cocktail of β‐Carboline Monoamine Oxidase Inhibitors in “Magic” Mushrooms • Absence of psilocybin in species of fungi previously reported to contain psilocybin and related tryptamine derivatives • Abwandlungsprodukte von Psilocybin und Psilocin. 2. Mitteilung über synthetische Indolverbindungen • The psilocybin-induced" state of drunkenness" in normal volunteers and schizophrenics. • Lysergic acid diethylamide and psilocybin revisited • Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience • Psilocybin Investigator's Brochure • Clinical potential of psilocybin as a treatment for mental health conditions • An improved, practical, and scalable five-step synthesis of psilocybin • Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience • Metabolic engineering of Saccharomyces cerevisiae for the production of psilocybin and related tryptamine derivatives • Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache • Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens' • XXXVIII. Comparison with Action of Methysergide and Psilocybin on Test Subjects • Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. • Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes • The Determination of Psilocin and Psilocybin in Hallucinogenic Mushrooms by HPLC Utilizing a Dual Reagent Acidic Potassium Permanganate and Tris (2, 2 … • An electroencephalographic analysis of personality-dependent performance under psilocybin • Memo on the Religious Implications of the Consciousness-Changing Drugs (LSD, Mescalin, Psilocybin) • Individual experiences in four cancer patients following psilocybin-assisted psychotherapy • Development of a psychotherapeutic model for psilocybin-assisted treatment of alcoholism • The in vitro inhibitory effect of psilocybin and related compounds on human cholinesterases • Psilocybin in Fruchtkörpern von Inocybe aeruginascens • Psilocybin intoxication • Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin • Listening for the logos: A study of reports of audible voices at high doses of psilocybin. • Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography. • Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression • Hypnotic induction of the interference of psilocybin with optically induced spatial distortion • Zur Pharmakologie von Psilocybin, einem Wirkstoff ausPsilocybe mexicana Heim • Psilocybin: from ancient magic to modern medicine • Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains • Peak experiences of psilocybin users and non-users • Availability of websites offering to sell psilocybin spores and psilocybin • Bis (4-acetoxy-N, N-dimethyltryptammonium) fumarate: a new crystalline form of psilacetin, an alternative to psilocybin as a psilocin prodrug • Treatment of childhood schizophrenia utilizing LSD and psilocybin • Psilocybin occasioned mystical‐type experiences • Skinner, Maslow, and psilocybin • Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention • Psilocybin for depression and anxiety associated with life-threatening illnesses • Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse • Enzymatische Synthese von Psilocybin • Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future • The Psilocybin Producer's Guide • Psilocybin: Psychotherapy or drug? • Measurement of handwriting area to pressure ratios during psilocybin-induced hallucinations • Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and … • Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin • Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio). • Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms • … -mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in “magic mushroom” … • Crystal structures of the Teonanácatl hallucinogens. Part I. Psilocybin C 12 H 17 N 2 O 4 P • Psilocin, psilocybin, serotonin and urea in Panaeolus cyanescens from various origin • Self-reported negative outcomes of psilocybin users: A quantitative textual analysis • Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing—study on P300 and mismatch negativity in healthy … • Psilocybin mushroom handbook: easy indoor & outdoor cultivation • Consumption of psilocybin-containing hallucinogenic mushrooms by young people • Psilocybin: Reaction with a fraction of rat brain • Time Contraction and Psychomotor Performance produced by 'Psilocybin' • It's time to take psilocybin seriously as a possible treatment for substance use disorders • Controlled sensory input: A note on the technic of drug evaluation with a preliminary report on a comparative study of sernyl, psilocybin, and LSD-25 • Psilocybin-Induced Transformations of Visual Space • Psilocybin and palliative end-of-life care • A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding • The effects of THC and psilocybin on paranormal phenomena • Psilocybin-assisted psychotherapy for dying cancer patients–aiding the final trip • Levels of psilocybin and psilocin in various types of mushrooms • Enzymatic route toward 6‐methylated baeocystin and psilocybin • Comparison of psilocin with psilocybin, mescaline and LSD-25 • Comparative effects of the administration of Taraxein, D-LSD, mescaline, and psilocybin to human volunteers • Psilocybin mushrooms of the world: an identification guide • Hallucinogenic Drug-Induced Behavior Under Sensory Attenuation: Prediction of Response to Psilocybin • Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016 • Psilocybin-induced altered states of consciousness: Tolerability, assessment, and prediction • Induction and extinction of psilocybin induced transformations of visual space • Psilocybin, lysergic acid diethylamide, mescaline, and drug-induced synesthesia • Psilocybin-assisted therapy for depression: How do we advance the field? • Lysergic acid diethylamide (LSD-25): XXXIV. Comparison with effect of psilocybin on the Siamese fighting fish • S‐Adenosyl‐l‐Methionine Salvage Impacts Psilocybin Formation in “Magic” Mushrooms • Psilocybin research at Johns Hopkins: A 2014 report • Psychedelic medicine: the healing powers of LSD, MDMA, psilocybin, and ayahuasca • Psilocybin in end of life care: Implications for further research • Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A … • Research on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice • What psilocybin taught me about dying • Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms • Altered states: psilocybin for treatment-resistant depression • Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache • The Psilocybin Solution: The role of sacred mushrooms in the quest for meaning • The role of psychedelics in palliative care reconsidered: A case for psilocybin • Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin • On travels in the universe of the soul: reports on self-experiments with delysid (LSD) and psilocybin (CY) • Sixty seconds on... psilocybin • Timothy Leary: The Harvard years: Early writings on LSD and psilocybin with Richard Alpert, Huston Smith, Ralph Metzner, and others • Vorkommen von Psilocybin und Baeocystin in Fruchtkörpern von Pluteus salicinus • … Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging • Neurobiology of the effects of psilocybin in relation to its potential therapeutic targets • Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review • Elucidation of the structure and the synthesis of psilocybin • Psilocin, psilocybin, serotonin and urea in • Psilocybin Therapeutic Research: The Present and Future Paradigm • Simultaneous determination of γ-hydroxybutyric acid, ibotenic acid and psilocybin in saliva samples by capillary electrophoresis coupled with a contactless … • Psilocybin and spiritual experience • Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF) • Clinical, biochemical and psychologic effects of psilocybin. • Ethics and ego dissolution: the case of psilocybin • Understanding the religious import of mystical states of consciousness facilitated by psilocybin • Psilocybin: Promising results in double-blind trials require confirmation by real-world evidence • A phenomenological examination of psilocybin and its positive and persisting aftereffects • Magic mushroom explorer: Psilocybin and the awakening earth • EEG changes after psilocybin in organic brain lesions. • Psilocybin Therapy for Major Depressive Disorder • A new behavior change program using psilocybin. • Detection of psilocybin in species of Psilocybe, Panaeolus and Psathyrella. • Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and … • Altered trajectories in the dynamical repertoire of functional network states under psilocybin • … identification of basidiospores in hallucinogenic mushrooms cultivated in “grow-kits” seized by the police: LC-UV quali-quantitative determination of psilocybin and … • Psilocybin and Relationship Satisfaction • Consistency of psilocybin induced changes in the Minnesota Multiphasic Personality Inventory. • Psilocybin for depression: Considerations for clinical trial design • Psilocybin for the treatment of substance use disorders • Tolerability, assessment, and prediction of psilocybin-induced altered states of consciousness • Potential therapeutic effects of psilocybin/psilocin are minimized while possible adverse reactions are overrated • Psilocybin: a pharmacological profile. • A potential role for psilocybin in the treatment of obsessive-compulsive disorder • Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors • Detection of psilocybin mushroom analogs in chocolate: Incorporating current events into the undergraduate teaching laboratory • Biosynthesis of psilocybin in submerged culture of Psilocybe cubensis. 1. Incorporation of labelled tryptophan and tryptamine. • Occurrence of psilocybin in the sporophores of Psilocybe semilanceata • A biosynthetic sequence from tryptophan to psilocybin. • Occurrence of Psilocybin and Baeocystin in Fruit Bodies of Pluteus salicinus. • Studies on psilocybin and related compounds. I. Communication. Structure/activity relationship of oxyindole-derivatives with regard to their effect on the … • The occurrence of the psychotomimetic agent psilocybin in an Australian agaric, Psilocybe subaeruginosa • Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels • Additional evidence supporting the occurrence of psilocybin in Panaeolus foenisecii. • Expressive phenomenology of model psychoses (psilocybin). Comparison with self-description and psychic deficiency of performance • Exposure‐Response Analysis to Assess the Concentration‐QTc Relationship of Psilocybin/Psilocin • Psilocybin: panacea or placebo? • Psilocybin-public available psychodysleptic • Serotonin-like and antiserotonin properties of psilocybin and psilocin • Similarity of schizophrenia and the psilocybin syndrome as determined by objective methods. • Psilocybin-containing mushrooms, Upper Palaeolithic rock art and the neuropsychological model • Psilocybin-induced changes in psychologic function, electroencephalogram, and light-evoked potentials in human subjects. • Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim • Psilocybin compositions • Question-based Drug Development for psilocybin–Authors' reply • The effect of bufotenine, melatonin, psilocybin, and related compounds on the 5-hydroxytryptamine excitatory receptors of Helix aspersa neurons • The relationship of carbon and nitrogen nutrition of Psilocybe baeocystis to the production of psilocybin and its analogs. • Risiken und Nebenwirkungen von LSD, Psilocybin und MDMA in der Psychotherapie • Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot study • Kliniske erfaringer med psilocybin • A comparative literature survey of psilocybin and LSD-25 metabolism • Personality trait dependent performance under psilocybin. II. • Psilocybin reactivity and time contraction as measured by psychomotor performance • Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons • Psilocybin based therapy for cancer related distress, a systematic review and meta analysis • Psilocybin slows binocular rivalry switching through serotonin modulation. • Denver votes to decriminalise psilocybin mushrooms • Your Psilocybin Mushroom Companion: An Informative, Easy-to-Use Guide to Understanding Magic Mushrooms—From Tips and Trips to Microdosing and … • Psychedelic effects of psilocybin correlate with serotonin 2 A receptor occupancy and plasma psilocin levels • Effects of mescaline and psilocybin on dominance behavior of the rat. • Psilocybin and LSD in the Treatment of Depression and Anxiety • How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans. • Abductin: a rubber-like protein from the internal triangular hinge ligament of Pecten • Psilocybe semilanceata (Fr.) Quel.(Spitzkegliger Kahlkopf): Nachweis von Psilocybin in deutschen Funden • An Adaptive Cognitive Temporal-Causal Model for Extreme Emotion Extinction Using Psilocybin • Unifying electron transfer mechanism for psilocybin and psilocin. • Compositions and methods comprising a psilocybin derivative • Obtaining psilocybin and psilocin from fungal material • Compositions comprising a psilocybin derivative and a cannabinoid • THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression • The effects of Psilocybin, dextro‐amphetamine and placebo on performance of the trail making test • Synthesis of baeocystin, a natural psilocybin analogue • Decomposing the Shadow: Lessons from the Psilocybin Mushroom • INTEGRATING PSILOCYBIN AND EXISTENTIAL-HUMANISTIC PSYCHOTHERAPY FOR PATHOLOGICAL GAMBLING TREATMENT: A NEW PERSPECTIVE. • Magic truffles or Philosopher's stones: a legal way to sell psilocybin? • On similar linguistic structures in creative performance and psilocybin-induced experience. • Fungi containing psilocybin hallucinogens. Wild Danish mushrooms containing intoxicants. • Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice • Method of inducing therapeutic tranquilization with psilocybin and psilocin • Different reaction of focal and diffuse epileptic EEG activity to psilocybin. • Towards a molecular approach for the identification of fungal taxa that contain psilocybin • Mushroom Medicine: The Healing Power of Psilocybin & Sacred Entheogen History • A social and cultural history of the federal prohibition of psilocybin • Profiles of psychedelic drugs. Psilocybin. • Long-Term Analysis of Psilocybin in Cancer Patients With Distress • 5-MeO-DIPT, a psychedelic structurally related to psiloc (yb) in • The effects of psilocybin on EEG and behaviour in monkeys. • Chronic cluster headache: response to psilocybin • A/B Extraction and Isolation of Psilocybin • LA PSILOCYBIN~ E • The Therapeutic Potential of Psilocybin and 3, 4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder • HPLC analysis of hallucinogenic mushroom alkaloids (Psilocin and Psilocybin) applying Hydrophilic Interaction Chromatography (HILIC) • Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 69–84 • Possible uses of psilocybin and muscarin alkaloids in the chemotaxonomy of Inocybe (Fr.) Fr. • The Screening of Mushrooms Found in Trinidad to Determine the Presence of the Psychoactive Substances Psilocin and Psilocybin • Determination of psilocybin and psilocin in hallucinogenic mushrooms by HPLC with diode array and MS detection • The effects of d-amphetamine, 2, 5-dimethoxy-4-methyl-amphetamine (DOM), and psilocybin on fixed-interval responding in the rat. • Halluzinogene: LSD, Psilocybin und Mescalin • The Utility of Psilocybin in Managing Anxiety and Depression in Cancer Patients • Physostigmine reversal of psilocybin intoxication • An adaptive cognitive temporal-causal model for extreme emotion extinction using psilocybin • Conceptions and Attitudes towards Psilocybin Mushrooms • Psilocybin administration to healthy participants: safety and feasibility in a placebo-controlled study • The effects of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rats. • Role of Prefrontal Serotonin-2A Receptors in Self-experience During Psilocybin Induced Altered States • On the treatment of therapy-resistant neuroses with model psychoses (psilocybin) • Question-based Drug Development for psilocybin • the Potential of Psilocybin administration in terminal Cancer Patients • Mapping Psilocybin-Assisted Therapies: A Scoping Review • The effect of psilocybin upon the systemic, pulmonary, and coronary circulation of the intact dog. • Clinical experiences with psilocybin (CY 39 Sandoz) • A Review of the Effects of Psilocybin on Depression and Personality • … and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or … • Integrating Psilocybin and Existential-Humanistic Psychotherapy for Pathological Gambling Treatment: A New Perspective • erste Nachweis des Vorkommens von Psilocybin in Rsspilzen • Nachweis und quantitative Bestimmung von Psilocin-und Psilocybin in halluzinogenen Pilzen • The effect of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rabbits. • Effect of psilocybin on the behavior of normal mice & waltzing mice; comparison with lysergic acid monoethylamide & diethylamide • … of the carpophores and sclerotia in culture of Psilocybe mexicana Heim, a Mexican, hallucinogenic agaric, and the demonstration of the presence of psilocybin and … • Psychedelic revival: a mixed-methods analysis of recreational magic mushroom (psilocybin) use for transformational, micro-dosing and leisure purposes • Motivationen und Morphologie des Freizeitgebrauchs von Psychedelika (LSD, Psilocybin-Pilze): eine qualitative Interviewstudie • Quantitative measurement of time contraction induced by psilocybin. • The Efficacy of Psilocybin Compared to Selective Serotonin Reuptake Inhibitors in the Treatment of Adults with Major Depressive Disorder • Use of MDMA & Psilocybin in the Treatment of PTSD • Ego Death Resulting from Psilocybin Experiences: Exploring the Concept Within Mysticism • World Report Denver votes to decriminalise psilocybin mushrooms • Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up • Trial of psilocybin versus escitalopram for depression • The therapeutic potential of psilocybin • Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice • Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial • Investigation of the structure–Activity relationships of psilocybin analogues • Spontaneous and deliberate creative cognition during and after psilocybin exposure • Increased global integration in the brain after psilocybin therapy for depression • Rediscovering psilocybin as an antidepressive treatment strategy
• A Study of Psilocybin for Major Depressive Disorder (MDD) • UW Psilocybin Pharmacokinetics Study • Effects of Psilocybin in Anorexia Nervosa • Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease • Psilocybin for Treatment of Obsessive Compulsive Disorder • Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors • Persisting Effects of Psilocybin • Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study. • Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder • Psilocybin for the Treatment of Migraine Headache • The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression. • Repeat Dosing of Psilocybin in Migraine Headache • An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD) • Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms • Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients • Prophylactic Effects of Psilocybin on Chronic Cluster Headache • Effects of Psilocybin in Concussion Headache • Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder • Psilocybin and Depression • The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals • Effects of Psilocybin in Major Depressive Disorder • Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study • Adjunctive Effects of Psilocybin and Buprenorphine • Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion • Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept • Visual Surround Suppression and Perceptual Expectation Under Psilocybin • Psilocybin-facilitated Treatment for Cocaine Use • Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence • The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression • Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators • Psilocybin for the Treatment of Cluster Headache • Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma • Psychopharmacology of Psilocybin in Cancer Patients • Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety • Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators • Psilocybin Cancer Anxiety Study • A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence • Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin • Comparative Acute Effects of LSD, Psilocybin and Mescaline • The Neurobiological Effect of 5-HT2AR Modulation • Psilocybin and Spiritual Practice • Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects • PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder • Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self • LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders • Effects of Hallucinogens and Other Drugs on Mood and Performance • Precision Functional Brain Mapping in Psilocybin • Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study • Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer • The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder • Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study • Psilocybin for Psychological and Existential Distress in Palliative Care • The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression • Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder • Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder • The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density • Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression • Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy • Psilocybin-assisted CBT for Depression • Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease • Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder • Psilocybin Therapy for Depression in Bipolar II Disorder • The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation • Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder • Frontline Clinician Psilocybin Study • Psilocybin for Treatment-Resistant Depression • Exploratory Study of Low Dose Psilocybin • Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use • Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain • Psilocybin-assisted Therapy for Phantom Limb Pain • Psilocybin-facilitated Treatment for Chronic Pain • Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD • Pilot RECAP Study in Healthy Volunteers • Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care • Mood and Cognitive Effects of Psilocybin in Healthy Participants • Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA) • Psilocybin in Depression Resistant to Standard Treatments • Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder • Naturalistic Study of Microdosing With Psilocybin • Palliadelic Treatment to Reduce Psychological Distress in Persons With Inoperable Pancreatobiliary Cancer • Northwest Therapies Trauma Psilocybin Study Compassionate Use Study • Microdosing Psychedelics to Improve Mood • Open-label Study to Assess the Safety and Efficacy of TRP-8802 With Psychotherapy in Adult Participants With Fibromyalgia • Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults • Characterization of Altered Waking States of Consciousness in Healthy Humans • Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU) • Personality and Drug Use (PDU) • Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder • Effects of Psilocybin in Post-Treatment Lyme Disease • The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD • Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder • Effects of Repeated Psilocybin Dosing in OCD • Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder • Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought • Pragmatic Trial of Psilocybin Therapy in Palliative Care • Comparing the Effects of Psilocin and Psilocybin in Healthy Adults • Psilocybin Therapy in Advanced Cancer • The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder • Psilocybin Therapy for Chronic Low Back Pain • Psilocybin Versus Ketamine in Treatment-Resistant Depression • A Study of a Psilocybin Analog (CYB003) in Participants With Major Depressive Disorder • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Psychedelics

• Mindstate Design Labs • Enveric Biosciences • Particles • Matter Academy • Psyrise • Mobile Lads • Creso Pharma • PurMinds Neuropharma • The Intercollegiate Psychedelics Network • Psychedelic Pharmacists Assocation • Psycle • TripSitter Clinic • Dimensions • Ocean Bio • Floresta Retreat • The Mind Army • Within Center
• Postdoctoral Research Fellow/Research Associate
• The current status of psychedelics in psychiatry • Predicting responses to psychedelics: a prospective study
• Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Public Relations

• Integration Communications • KCSA • Mattio Communications • PRISMATICS • Psyrise • Trent & Company